| Kathy Vu, OD | |
|
11851 N 51st Ave, Suite 120, Glendale, AZ 85304-2809 | |
| (623) 414-6476 | |
| Not Available |
| Full Name | Kathy Vu |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 16 Years |
| Location | 11851 N 51st Ave, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073778601 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1631 (Arizona) | Primary |
| Provider Name | Kathy Vu Ngo Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336554542 PECOS PAC ID: 4183846231 Enrollment ID: O20141105002067 |
News Archive
Durata Therapeutics, Inc. announced today that it has acquired Vicuron Pharmaceuticals from Pfizer (PFE). Durata is a newly formed biopharmaceutical company that was created by a five-member venture capital syndicate to pursue late-stage clinical development of novel antibiotic programs. The acquisition was funded through a stock purchase by New Leaf Venture Partners, LLC, Domain Associates, LLC, Aisling Capital, Sofinnova Ventures Inc. and Canaan Partners.
Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.
A disaster or tragedy is unexpected and often brings out strong emotions. The Disaster Distress Helpline 1-800-985-5990 can provide immediate counseling to anyone who needs help in dealing with the tragedy in Boston.
Men with prostate cancer treated with a specialized type of radiation called intensity modulated radiation therapy (IMRT) have fewer gastrointestinal complications compared to patients treated with conventional three-dimensional conformal radiotherapy (3D-CRT), according to a study presented November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathy Vu, OD 11851 N 51st Ave, Suite 120, Glendale, AZ 85304-2809 Ph: (623) 414-6476 | Kathy Vu, OD 11851 N 51st Ave, Suite 120, Glendale, AZ 85304-2809 Ph: (623) 414-6476 |
News Archive
Durata Therapeutics, Inc. announced today that it has acquired Vicuron Pharmaceuticals from Pfizer (PFE). Durata is a newly formed biopharmaceutical company that was created by a five-member venture capital syndicate to pursue late-stage clinical development of novel antibiotic programs. The acquisition was funded through a stock purchase by New Leaf Venture Partners, LLC, Domain Associates, LLC, Aisling Capital, Sofinnova Ventures Inc. and Canaan Partners.
Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.
A disaster or tragedy is unexpected and often brings out strong emotions. The Disaster Distress Helpline 1-800-985-5990 can provide immediate counseling to anyone who needs help in dealing with the tragedy in Boston.
Men with prostate cancer treated with a specialized type of radiation called intensity modulated radiation therapy (IMRT) have fewer gastrointestinal complications compared to patients treated with conventional three-dimensional conformal radiotherapy (3D-CRT), according to a study presented November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
› Verified 9 days ago
Dr. Margarita Alicia Coca, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 7700 W Arrowhead Towne Ctr, Glendale, AZ 85308 Phone: 623-486-2020 | |
Dr. Diana Vega Hernandez, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 7260 W Bell Rd, Glendale, AZ 85308 Phone: 623-486-1888 Fax: 623-486-8001 | |
Michael L Berger Od Pc Optometrist Medicare: Medicare Enrolled Practice Location: 6677 W Thunderbird Rd #b132, Glendale, AZ 85306 Phone: 602-978-1199 | |
Stacie L Westen Od Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5605 W Northern Ave, Glendale, AZ 85301 Phone: 623-934-6917 | |
Jessica Chow, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5707 W Northern Ave, Suite 106, Glendale, AZ 85301 Phone: 602-512-3299 Fax: 602-512-3303 | |
Florencia Yeh, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5865 W Utopia Rd, Glendale, AZ 85308 Phone: 623-806-7265 | |
Krissa Janae Lindsay, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 17550 N 79th Ave, Glendale, AZ 85308 Phone: 623-776-4006 |